Internal Server Error

Spectral MD - About the company

Spectral MD is a public company based in Dallas (United States), founded in 2009 by Michael DiMaio. It operates as a Develops of AI-based wound imaging system. Spectral MD has raised $1.07M in funding. The company has 16 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like MolecuLight, Kent Imaging and ARANZ Medical.

Company Details

Develops of AI-based wound imaging system. Its flagship product DeepView Wound Imaging System is an imaging device that captures visible and infrared images of burns, chronic wounds, and other pathological conditions of the skin.
Key Metrics
Founded Year
2009
Location
Dallas, United States
Stage
Public
Total Funding
$1.07M in 7 rounds
Ranked
Annual Revenue
$10M - $50M as on Dec 31, 2025
Employee Count
83 as on Sep 30, 2026
Similar Companies
Exit Details
Public

Spectral MD's IPO details

Spectral MD got listed on Jun 22, 2021.
Click here to take a look at Spectral MD's IPO in detail
Sign up to download Spectral MD's company profile

Spectral MD's funding and investors

Spectral MD has raised a total funding of $1.07M over 7 rounds. Its first funding round was on Mar 11, 2011. Its latest funding round was a Grant (prize money) round on Apr 18, 2023 for $*****. 1 investor participated in its latest round. Spectral MD has 5 institutional investors.

Here is the list of recent funding rounds of Spectral MD:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Apr 18, 2023
8260654
Grant (prize money)
1062931
4937739
8350881
1744395
Aug 30, 2022
6103000
Grant (prize money)
1158777
5944828
5972309
Sep 06, 2021
5531493
Grant (prize money)
4884489
4675386
8255069
lockAccess funding benchmarks and valuations. Sign up today!

Spectral MD's founders and board of directors

Founder? Claim Profile
The founders of Spectral MD is Michael DiMaio. Michael DiMaio is the CEO of Spectral MD.
Here are the details of Spectral MD's key team members:

Spectral MD's employee count trend

Spectral MD has 83 employees as of Sep 26. Here is Spectral MD's employee count trend over the years:
Employee count trend for Spectral MD
lockUncover Spectral MD's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Spectral MD's Competitors and alternates

Top competitors of Spectral MD include MolecuLight, Kent Imaging and ARANZ Medical. Here is the list of Top 10 competitors of Spectral MD, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for MolecuLight
MolecuLight
2013, Toronto (Canada), Series D
Provider of point of care device for wound assessment
$43.2M
57/100
2nd
Logo for Kent Imaging
Kent Imaging
2006, Calgary (Canada), Series B
Provider of near-infrared imaging solutions for wound care
$15M
47/100
3rd
Logo for Spectral MD
Spectral MD
2009, Dallas (United States), Public
Develops of AI-based wound imaging system
$1.07M
42/100
4th
Logo for ARANZ Medical
ARANZ Medical
1995, Christchurch (New Zealand), Late Stage
3D scanning applications for wound care and orthotics/prosthetics.
$3.4M
33/100
5th
Logo for CutoSense
CutoSense
2016, Turku (Finland), Seed
Developer of a medical system for treating wounds
-
30/100
6th
Logo for WoundVision
WoundVision
2006, Indianapolis (United States), Unfunded
Wound imaging and documentation solutions to standardize assessment and streamline workflows
-
-
29/100
7th
Logo for Eykona Technologies
Eykona Technologies
2007, Oxford (United Kingdom), Late Stage
Provider of portable 3D imaging systems for dermatological applications
$1.86M
27/100
8th
Logo for Halo Biologics
Halo Biologics
2022, West Palm Beach (United States), Unfunded
Developer of medical device products for wound care and orthopedic applications
-
-
26/100
9th
Logo for RastaCare Meditech
RastaCare Meditech
2020, Canada, Unfunded
Developer of non-invasive imaging devices for the diagnosis of wounds
-
-
24/100
10th
Logo for Omnidermal
Omnidermal
2017, Parma (Italy), Funding Raised
Developer of an AI enabled wound monitoring device
-
 
24/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Spectral MD's competitors? Click here to see the top ones

Spectral MD's Investments and acquisitions

Spectral MD has made no investments or acquisitions yet.

Reports related to Spectral MD

Here is the latest report on Spectral MD's sector:

News related to Spectral MD

lockFilter this list
•
Appointment of Spectral MD Chief Operating OfficerNewswire•Nov 09, 2022•Spectral MD
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Spectral MD

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford